Literature DB >> 15183556

Caecocystoplasty for intractable interstitial cystitis: long-term results.

Aniruddha Chakravarti1, Suresh Ganta, Bhaskar Somani, Malcolm Anthony Jones.   

Abstract

OBJECTIVE: To evaluate the role of orthotopic substitution caecocystoplasty in intractable interstitial cystitis refractory to conservative measures by looking at long-term follow-up results. PATIENTS AND METHODS: We present a retrospective review of eleven patients who underwent a trigone-preserving orthotopic substitution caecocystoplasty for intractable classical interstitial cystitis. All patients received conservative treatment for a mean period of three years. They were followed up for a mean period of nine years (range 4-14 years) with evaluation of symptoms, biochemistry, ultrasound scan and flexible cystoscopy.
RESULTS: Symptomatic relief was universal with an increase of bladder capacity to normal. There was no mortality and the postoperative morbidity was minimal. Intermittent self-catheterisation due to high residual volumes was necessary in two patients. There was no significant urinary reflux or metabolic complications noted. Two patients required a cystectomy after four and six years respectively due to recurrent trigonal disease in one and urethro-trigonal hypersensitivity following intermittent self-catheterisation in the other patient. One patient developed an advanced adenocarcinoma in the caecal segment seven years following the primary operation.
CONCLUSION: A sustained relief of symptoms is noted after trigone-preserving orthotopic substitution caecocystoplasty in intractable classical interstitial cystitis. It may not be appropriate in patients with urethro-trigonal disease or hypersensitivity. There is low long-term morbidity due to the operation but is associated with malignancy in the augmentate. Long-term follow-up is necessary to identify malignant change in the bladder. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Year:  2004        PMID: 15183556     DOI: 10.1016/j.eururo.2004.03.004

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  1 in total

1.  Bladder utility symptom scale: a new patient reported outcome measure for health-related quality of life in bladder cancer.

Authors:  Bhaskar K Somani
Journal:  Transl Androl Urol       Date:  2018-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.